Press release
Psychiatric Disorder Indication Vocal Biomarker Market to Generate 130 Mn Revenues by 2027-end | Beyond Verbal, Sonde Health, IBM Corporation
According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments.Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/719/vocal-biomarker-market
Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.
Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=719
Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success
Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.
CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=719
CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.
Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend
Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/719/S
Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders.
Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=719
Fact.MR’s report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/719/vocal-biomarker-market
Content Source: https://www.factmr.com/media-release/472/vocal-biomarker-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psychiatric Disorder Indication Vocal Biomarker Market to Generate 130 Mn Revenues by 2027-end | Beyond Verbal, Sonde Health, IBM Corporation here
News-ID: 2279904 • Views: …
More Releases from Fact.MR
CNG Vehicles Market Forecasted Surge to US$ 312 Billion by 2033 | Fact.MR
The CNG Vehicles Market is expected to rise globally between 2023 and 2033 at an impressive 10.9% CAGR, with current sales of US$ 110.5 billion. By the end of 2033, the global market for CNG vehicles is anticipated to be valued US$ 312 billion. Compressed natural gas is the main fuel source for cars that run on it. The popularity of CNG vehicles has increased dramatically over the past 20…
Pressure Ulcer Relief Products Market is estimated to valuation of US$ 6.7 billi …
According to a recent Fact.MR report, the pressure Ulcer Relief Products Market will grow at a high-value compound annual growth rate (CAGR) of 6.1% between 2022 and 2026. By the end of 2026, the market is expected to be valued US$ 6.7 billion. In the years to come, the market for pressure ulcer relief products is expected to rise primarily due to the aging of the population and the increasing…
Hip Reconstruction Devices Market Scaling Towards a $12.15 Billion Horizon by 20 …
The growing number of older people worldwide is driving the demand for Hip Reconstruction Devices Market. The necessity for hip reconstruction has increased due to hip fractures, osteoarthritis, and the progressive degeneration of joints in older adults. This has a significant effect on the market for hip reconstruction devices. As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, the global hip reconstruction devices market…
Massive Open Online Course (MOOC) Market is Projected to Expand at 32% CAGR and …
The global market for massive open online courses (MOOCs) is projected to grow at a compound annual growth rate (CAGR) of 32% through 2034. This growth is expected to elevate the market value from $13.2 billion in 2024 to $212.7 billion by the end of 2034.
A massive open online course (MOOC) is a web-based distance learning program designed for the participation of large numbers of geographically dispersed students.
Massive Open Online…
More Releases for CROs
Global CROs Services Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities.
Browse 155 Market Data Tables and 115…
Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights
A contract research organization (CRO) is a company that…
Contract Research Organization Services (CROs) Market brisk growth 2025
Contract Research Organization Services (CROs): Snapshot
Contract Research Organization or CRO is described as an organization which provide assistance and services generally to the pharmaceutical and biotechnology industries in the form of data research, drug tests, clinical trials, post development marketing, and related services for the development of both drugs and medical devices. CROs are available in a vast range from large, international full service organizations to small, niche specialty groups…
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”.
Vezzoli’s Paper Abstract
In the case of non-normal study outcomes, a nonparametric approach may be used…
CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS
Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.…
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities.
CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team…
